Insiders Trades
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Stock: price and insider trades · China
万泰生物
No insider purchase over the last 90 days. The latest was filed 08 Sept 2021.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.: what insiders have been doing
This page follows insider dealings at Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. has had no insider filing for more than a year; the last one goes back to 28 May 2025.
Since 2021, the database holds 1 purchase and 20 sales by insiders of the company.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Insider Decl.
21
Thresholds
n/a
Buy Volume
€2,491
1 ops. · all time
Sell Volume
€111M
20 ops. · all time
Who traded when
BuySale叶祥忠1 sale
赵灵芝1 sale
Since the insiders bought
- -2.4%Entry CN¥94.14 · Close at T+365 CN¥91.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Underperform (bearish), based on 1 analysts. Average price target: CN¥32.40.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,242 of 24,148 companies
31.1
score / 100
Value28
Quality34
FCF yld-2.1%
Earn yld-1.2%
EV/EBITDA·
ROE-3.3%
Gross mgn49%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥27.34
Analyst consensus
1 analystsUnderperform
CN¥32.40Target CN¥32.40(+19%)CN¥32.40
Income statement
RevenueCN¥1.8B
Gross profitCN¥897.1M49% margin
EBITDA-CN¥128.7M-7% margin
Net income-CN¥398.3M-18.9% margin
Valuation
P/Book2.9x
Beta0.74
Balance sheet & cash
Market capCN¥34.6B
Total debtCN¥354.4M
Free Cash Flow-CN¥715.4M
Debt / Equity3%
Profitability & ownership
ROE-3.3%
ROA-3.1%
% insiders82.1%
% institutions2.5%
Last declaration on 28 May 2025
Declarations21 total
21 of 21 declarations
About Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
万泰生物 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and manufacturing of biological products and diagnostics.
